Brain structure in people at ultra-high risk of psychosis, patients with first-episode schizophrenia, and healthy controls: A VBM study

Schizophrenia Research

Volumn 161, Issue 2-3, 2015, Pages 169-176

  Nenadic, Igor ^a   Dietzek, Maren ^a   Schönfeld, Nils ^a   Lorenz, Carsten ^a   Gussew, Alexander ^a   Reichenbach, Jürgen R ^a   Sauer, Heinrich ^a   Gaser, Christian ^a   Smesny, Stefan ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

At risk mental state (ARMS); Magnetic resonance imaging (MRI); Psychosis; Schizophrenia; Ultra high risk (UHR); Voxel based morphometry (VBM)

Indexed keywords

ADULT; AMYGDALOID NUCLEUS; ARTICLE; BRAIN REGION; CAUDATE NUCLEUS; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; FRONTAL LOBE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GRAY MATTER; HIGH RISK POPULATION; HIPPOCAMPUS; HUMAN; INSULA; MALE; NEUROANATOMY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; SCHIZOPHRENIA; TEMPORAL CORTEX; ULTRA HIGH RISK GROUP; VOXEL BASED MORPHOMETRY; WHITE MATTER; BRAIN; CASE CONTROL STUDY; IMAGE PROCESSING; PATHOLOGY; PATHOPHYSIOLOGY; PRODROMAL SYMPTOM; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOSIS; RISK FACTOR; YOUNG ADULT;

ADULT; BRAIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; PRODROMAL SYMPTOMS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; YOUNG ADULT;

EID: 84921598131     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2014.10.041     Document Type: Article

References (31)

1. Addington J., Heinssen R. Prediction and prevention of psychosis in youth at clinical high risk. Annu. Rev. Clin. Psychol. 2012, 8:269-289.
2. Aiello G., Horowitz M., Hepgul N., Pariante C.M., Mondelli V. Stress abnormalities in individuals at risk for psychosis: a review of studies in subjects with familial risk or with "at risk" mental state. Psychoneuroendocrinology 2012, 37(10):1600-1613.
3. Bois C., Whalley H., McIntosh A., Lawrie S. Structural magnetic resonance imaging markers of susceptibility and transition to schizophrenia: a review of familial and clinical high risk population studies. J. Psychopharmacol. 2014, (in press, http://www.ncbi.nlm.nih.gov/pubmed/25049260).
4. Chan R.C., Di X., McAlonan G.M., Gong Q.Y. Brain anatomical abnormalities in high-risk individuals, first-episode, and chronic schizophrenia: an activation likelihood estimation meta-analysis of illness progression. Schizophr. Bull. 2011, 37(1):177-188.
5. Cooper D., Barker V., Radua J., Fusar-Poli P., Lawrie S.M. Multimodal voxel-based meta-analysis of structural and functional magnetic resonance imaging studies in those at elevated genetic risk of developing schizophrenia. Psychiatry Res. 2014, 221(1):69-77.
6. Daneault J.G., Stip E., Refer O.S.G. Genealogy of instruments for prodrome evaluation of psychosis. Front. Psychiatry 2013, 4:25.
7. Fusar-Poli P. Voxel-wise meta-analysis of fMRI studies in patients at clinical high risk for psychosis. J. Psychiatry Neurosci. 2012, 37(2):106-112.
8. Ganzola R., Maziade M., Duchesne S. Hippocampus and amygdala volumes in children and young adults at high-risk of schizophrenia: research synthesis. Schizophr. Res. 2014, 156(1):76-86.
9. Glahn D.C., Laird A.R., Ellison-Wright I., Thelen S.M., Robinson J.L., Lancaster J.L., Bullmore E., Fox P.T. Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis. Biol. Psychiatry 2008, 64(9):774-781.
10. Jung W.H., Jang J.H., Byun M.S., An S.K., Kwon J.S. Structural brain alterations in individuals at ultra-high risk for psychosis: a review of magnetic resonance imaging studies and future directions. J. Korean Med. Sci. 2010, 25(12):1700-1709.
11. Kohler C.G., Richard J.A., Brensinger C.M., Borgmann-Winter K.E., Conroy C.G., Moberg P.J., Gur R.C., Gur R.E., Calkins M.E. Facial emotion perception differs in young persons at genetic and clinical high-risk for psychosis. Psychiatry Res. 2014, 216(2):206-212.
12. Koutsouleris N., Gaser C., Jager M., Bottlender R., Frodl T., Holzinger S., Schmitt G.J., Zetzsche T., Burgermeister B., Scheuerecker J., Born C., Reiser M., Moller H.J., Meisenzahl E.M. Structural correlates of psychopathological symptom dimensions in schizophrenia: a voxel-based morphometric study. NeuroImage 2008, 39(4):1600-1612.
13. Koutsouleris N., Meisenzahl E.M., Davatzikos C., Bottlender R., Frodl T., Scheuerecker J., Schmitt G., Zetzsche T., Decker P., Reiser M., Moller H.J., Gaser C. Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition. Arch. Gen. Psychiatry 2009, 66(7):700-712.
14. Koutsouleris N., Schmitt G.J., Gaser C., Bottlender R., Scheuerecker J., McGuire P., Burgermeister B., Born C., Reiser M., Moller H.J., Meisenzahl E.M. Neuroanatomical correlates of different vulnerability states for psychosis and their clinical outcomes. Br. J. Psychiatry 2009, 195(3):218-226.
15. Koutsouleris N., Borgwardt S., Meisenzahl E.M., Bottlender R., Moller H.J., Riecher-Rossler A. Disease prediction in the at-risk mental state for psychosis using neuroanatomical biomarkers: results from the FePsy study. Schizophr. Bull. 2012, 38(6):1234-1246.
16. Lawrie S.M., McIntosh A.M., Hall J., Owens D.G., Johnstone E.C. Brain structure and function changes during the development of schizophrenia: the evidence from studies of subjects at increased genetic risk. Schizophr. Bull. 2008, 34(2):330-340.
17. Leung M., Cheung C., Yu K., Yip B., Sham P., Li Q., Chua S., McAlonan G. Gray matter in first-episode schizophrenia before and after antipsychotic drug treatment. Anatomical likelihood estimation meta-analyses with sample size weighting. Schizophr. Bull. 2011, 37(1):199-211.
18. Nenadic I., Sauer H., Gaser C. Distinct pattern of brain structural deficits in subsyndromes of schizophrenia delineated by psychopathology. NeuroImage 2010, 49(2):1153-1160.
19. Nenadic I., Yotter R.A., Sauer H., Gaser C. Cortical surface complexity in frontal and temporal areas varies across subgroups of schizophrenia. Hum. Brain Mapp. 2014, 35(4):1691-1699.
20. Palaniyappan L., Balain V., Liddle P.F. The neuroanatomy of psychotic diathesis: a meta-analytic review. J. Psychiatr. Res. 2012, 46(10):1249-1256.
21. Schultze-Lutter F., Ruhrmann S., Fusar-Poli P., Bechdolf A., Schimmelmann B.G., Klosterkotter J. Basic symptoms and the prediction of first-episode psychosis. Curr. Pharm. Des. 2012, 18(4):351-357.
22. Smieskova R., Marmy J., Schmidt A., Bendfeldt K., Riecher-Rssler A., Walter M., Lang U.E., Borgwardt S. Do subjects at clinical high risk for psychosis differ from those with a genetic high risk?-A systematic review of structural and functional brain abnormalities. Curr. Med. Chem. 2013, 20(3):467-481.
23. Sprooten E., Papmeyer M., Smyth A.M., Vincenz D., Honold S., Conlon G.A., Moorhead T.W., Job D., Whalley H.C., Hall J., McIntosh A.M., Owens D.C., Johnstone E.C., Lawrie S.M. Cortical thickness in first-episode schizophrenia patients and individuals at high familial risk: a cross-sectional comparison. Schizophr. Res. 2013, 151(1-3):259-264.
24. Stafford M.R., Jackson H., Mayo-Wilson E., Morrison A.P., Kendall T. Early interventions to prevent psychosis: systematic review and meta-analysis. BMJ 2013, 346:f185.
25. Takahashi T., Yung A.R., Yucel M., Wood S.J., Phillips L.J., Harding I.H., Soulsby B., McGorry P.D., Suzuki M., Velakoulis D., Pantelis C. Prevalence of large cavum septi pellucidi in ultra high-risk individuals and patients with psychotic disorders. Schizophr. Res. 2008, 105(1-3):236-244.
26. Torres U.S., Portela-Oliveira E., Borgwardt S., Busatto G.F. Structural brain changes associated with antipsychotic treatment in schizophrenia as revealed by voxel-based morphometric MRI: an activation likelihood estimation meta-analysis. BMC Psychiatry 2013, 13:342.
27. Wood S.J., Yucel M., Velakoulis D., Phillips L.J., Yung A.R., Brewer W., McGorry P.D., Pantelis C. Hippocampal and anterior cingulate morphology in subjects at ultra-high-risk for psychosis: the role of family history of psychotic illness. Schizophr. Res. 2005, 75(2-3):295-301.
28. Wood S.J., Pantelis C., Velakoulis D., Yucel M., Fornito A., McGorry P.D. Progressive changes in the development toward schizophrenia: studies in subjects at increased symptomatic risk. Schizophr. Bull. 2008, 34(2):322-329.
29. Wood S.J., Reniers R.L., Heinze K. Neuroimaging findings in the at-risk mental state: a review of recent literature. Can. J. Psychiatry 2013, 58(1):13-18.
30. Yung A.R., Nelson B. Young people at ultra high risk for psychosis: a research update. Early Interv. Psychiatry 2011, 5(Suppl. 1):52-57.
31. Yung A., Phillips L., McGorry P., Ward J., Donovan K., Thompson K. Comprehensive assessment of at risk mental states (CAARMS) 2002, PACE Clinic. Department of Psychiatry, University of Melbourne, Melbourne, Melbourne.